Contribute Information
Can you contribute information about this project?
Contact the EWS Team
According to the Bank’s website, the project consists of an equity co-investment of up to EUR 25 million, alongside Mid Europa, for the acquisition of Famar, a European pharmaceutical Contract Development and Manufacturing Organisation ("CDMO").
The Bank's equity investment alongside Mid Europa will enable the transformation of Famar towards higher-value-added products with an enhanced set of R&D capabilities, and a potential for the Company to become a platform for further acquisitions in the Central and South Eastern Europe region.
Acquiring an indirect shareholding via an intermediary fund of a pharmaceutical Contract Development and Manufacturing Organisation with operations located in the EU, is associated with identifiable risks which can be readily addressed post-acquisition by the fund.
Equity co-investment of up to EUR 25 million (EUR 24,250,000)
Headquartered in Greece, Famar is a mid-sized Greek pharma CDMO specializing in manufacturing and distribution of a wide range of pharmaceutical, consumer health and cosmetic products, with production sites in Greece, Spain and Italy. Famar was founded in 1949 as a Greek family business and has been private equity-owned since late 2018. The Company currently employs c. 1,700 people and has a diversified blue-chip customer base of c. 100 customers.
Private Actor 1 | Private Actor 1 Role | Private Actor 1 Sector | Relation | Private Actor 2 | Private Actor 2 Role | Private Actor 2 Sector |
---|---|---|---|---|---|---|
- | - | - | - | Famar | Client | - |
- | - | - | - | MidEuropa Investor Relations | Investor | - |
COMPANY CONTACT INFORMATION
MidEuropa Investor Relations
IR@mideuropa.com
+44 (0) 207 886 3600
https://www.famar-group.com/
ACCESS TO INFORMATION
You can request information by emailing: accessinfo@ebrd.com or by using this electronic form: https://www.ebrd.com/eform/information-request
ACCOUNTABILITY MECHANISM OF EBRD
The Project Complaint Mechanism (PCM) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an European Bank for Reconstruction and Development (EBRD)-financed project. If you submit a complaint to the PCM, it may assess compliance with EBRD's own policies and procedures to prevent harm to the environment or communities or it may assist you in resolving the problem that led to the complaint through a dialogue with those implementing the project. Additionally, the PCM has the authority to recommend a project be suspended in the event that harm is imminent.
You can contact the PCM at: pcm@ebrd.com or you can submit a complaint online using an online form at: http://www.ebrd.com/eform/pcm/complaint_form?language=en
You can learn more about the PCM and how to file a complaint at: http://www.ebrd.com/work-with-us/project-finance/project-complaint-mechanism.html